Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® Compared to SYMBICORT® TURBOHALER®

Study Title
Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAXֲ® as Compared to SYMBICORTֲ® TURBOHALERֲ® as Treatment for Adult Patients With Asthma
Teva Identifier
BFS-AS-40035 | 2013-004630-14
ClinicalTrials.gov Identifier
NCT02062463
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 75 Years
Trial Duration
06/01/2014 - 04/01/2015
Phase
Phase 4

Study Type

Interventional